Equally rare bona fide B-cell lymphoblastic leukemias/lymphomas with TdT expression and MYC translocations or, even rarer, MYC/BCL2 double hit have been mainly reported in the pediatric or adolescent setting [53,54] and are molecularly different from DLBCL/HGBL-MYC/BCL2. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.